PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmuscle weakness
MeSH D018908 - muscle weakness
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D020879:Neuromuscular manifestations
0 Companies
0 Drugs
Success rate
D009135:Muscular diseases
0 Companies
0 Drugs
Success rate
D010335:Pathologic processes
0 Companies
0 Drugs
Success rate
D018908: 
Muscle weakness
$
Success rate
D000094222:Dropped head syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Merck & CoGuanidine Guanidine  1982-01-01   
Clinical Trials
Historical Success Rate
Phase 1
75%
3/4
Phase 2
60%
9/15
Phase 3
18%
2/11
Approved: 1Overall Success rate: 8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use